Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
3.205
-0.035 (-1.08%)
At close: Mar 9, 2026, 4:00 PM EDT
3.120
-0.085 (-2.65%)
After-hours: Mar 9, 2026, 4:04 PM EDT

Imunon Market Cap

Imunon has a market cap or net worth of $10.90 million as of March 9, 2026. Its market cap has decreased by -13.51% in one year.

Market Cap
10.90M
Enterprise Value
6.87M
1-Year Change
-13.51%
Ranking
Category
Stock Price
$3.21

Market Cap Chart

Since March 1, 1999, Imunon's market cap has decreased from $37.70M to $10.90M, a decrease of -71.09%. That is a compound annual growth rate of -4.49%.

History

DateMarket Cap% Change
Mar 6, 20269.90M-15.38%
Dec 31, 202511.70M-15.22%
Dec 31, 202413.80M115.63%
Dec 29, 20236.40M-36.00%
Dec 30, 202210.00M-78.59%
Dec 31, 202146.70M75.56%
Dec 31, 202026.60M-31.62%
Dec 31, 201938.90M47.35%
Dec 31, 201826.40M-38.60%
Dec 29, 201743.00M444.30%
Dec 30, 20167.90M-82.29%
Dec 31, 201544.60M-4.09%
Dec 31, 201446.50M-12.10%
Dec 31, 201352.90M-81.56%
Dec 31, 2012286.80M531.72%
Dec 30, 201145.40M73.95%
Dec 31, 201026.10M-34.09%
Dec 31, 200939.60M77.58%
Dec 31, 200822.30M-30.75%
Dec 31, 200732.20M57.07%
Dec 29, 200620.50M-52.87%
Dec 30, 200543.50M-52.51%
Dec 31, 200491.60M-52.76%
Dec 31, 2003193.90M367.23%
Dec 31, 200241.50M-26.29%
View and export this data all the way back to 1999. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
CytoMed Therapeutics 12.12M
Soligenix 12.00M
Cellectar Biosciences 11.70M
Chemomab Therapeutics 11.57M
CalciMedica 11.45M
Akari Therapeutics, 11.37M
BiomX 10.85M
Liminatus Pharma 10.42M
Market Cap Rankings